Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19
- Written by PR Newswire
![]() |
HONG KONG, Oct. 24, 2022 /PRNewswire/ -- A randomised, double-blind controlled study conducted by The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) showed that SIM01, a CUHK-developed microbiome formula, successfully reduced adverse events in high-risk individuals such as elderly subjects and diabetics following...















